Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor Malignancies

This study is ongoing, but not recruiting participants.

Sponsor:

Collaborators:

Brigham and Women's Hospital

Massachusetts General Hospital

Information provided by (Responsible Party):

Peter C. Enzinger, MD, Dana-Farber Cancer Institute

ClinicalTrials.gov Identifier:

NCT00215501

First received: September 14, 2005

Last updated: November 30, 2012

Last verified: November 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	January 2013
Primary Completion Date:	September 2005 (Final data collection date for primary outcome measure)